# Extract of Ginkgo Biloba and Tardive Dyskinesia

> **NCT00672373** · PHASE3 · COMPLETED · sponsor: **Beijing HuiLongGuan Hospital** · enrollment: 157 (actual)

## Conditions studied

- Tardive Dyskinesia
- Schizophrenia

## Interventions

- **DRUG:** Extract of Ginkgo Biloba (EGb-761 capsules)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00672373
- **Lead sponsor:** Beijing HuiLongGuan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-05
- **Final completion:** 2007-08
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2008-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672373, "Extract of Ginkgo Biloba and Tardive Dyskinesia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00672373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*